Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03155620
Title Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

sarcoma

non-Hodgkin lymphoma

lymphoma

medulloblastoma

hepatoblastoma

rhabdomyosarcoma

neuroectodermal tumor

Advanced Solid Tumor

lymphatic system cancer

Ewing sarcoma

childhood ependymoma

central nervous system cancer

neuroblastoma

childhood osteosarcoma

Therapies

Tazemetostat

Larotrectinib

LY3023414

Vemurafenib

Palbociclib

Olaparib

Ulixertinib

Erdafitinib

Selumetinib

Ensartinib

Age Groups: adult | child
Covered Countries USA